Teladoc Health Files 8-K on Operations and Financial Condition
Ticker: TDOC · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, SEC-filing
TL;DR
**Teladoc Health just dropped an 8-K on its financials, so keep an eye out for the details!**
AI Summary
Teladoc Health, Inc. filed an 8-K on February 20, 2024, to report on its results of operations and financial condition, as well as to include financial statements and exhibits. The filing indicates that the earliest event reported was also on February 20, 2024. The company, incorporated in Delaware with IRS number 04-3705970, maintains its principal executive offices at 2 Manhattanville Road, Suite 203, Purchase, NY 10577.
Why It Matters
This filing provides an update on Teladoc Health's financial performance and operational status, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results and does not indicate any immediate new risks.
Key Players & Entities
- Teladoc Health, Inc. (company) — Registrant
- February 20, 2024 (date) — Date of Report and earliest event reported
- Delaware (company) — State of incorporation
- 04-3705970 (dollar_amount) — I.R.S. Employer Identification Number
- 2 Manhattanville Road, Suite 203, Purchase, NY 10577 (company) — Principal executive offices address
FAQ
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on February 20, 2024.
What items of information are included in this 8-K filing?
The 8-K filing includes information on Results of Operations and Financial Condition, and Financial Statements and Exhibits.
Where are Teladoc Health, Inc.'s principal executive offices located?
Teladoc Health, Inc.'s principal executive offices are located at 2 Manhattanville Road, Suite 203, Purchase, NY 10577.
What is Teladoc Health, Inc.'s IRS Employer Identification Number?
Teladoc Health, Inc.'s IRS Employer Identification Number is 04-3705970.
In which state is Teladoc Health, Inc. incorporated?
Teladoc Health, Inc. is incorporated in Delaware.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-02-20 16:15:01
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share TDOC The New York Stock Excha
Filing Documents
- tdoc-20240220.htm (8-K) — 27KB
- tdoc-20231231xexx991.htm (EX-99.1) — 424KB
- image_0a.jpg (GRAPHIC) — 6KB
- 0001477449-24-000017.txt ( ) — 618KB
- tdoc-20240220.xsd (EX-101.SCH) — 2KB
- tdoc-20240220_lab.xml (EX-101.LAB) — 24KB
- tdoc-20240220_pre.xml (EX-101.PRE) — 13KB
- tdoc-20240220_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 20, 2024, Teladoc Health, Inc. (the "Company") issued a press release relating to its financial results for the fourth quarter and full year 2023. A copy of the press release, which is incorporated by reference herein, is attached hereto as Exhibit 99.1. The foregoing information (including the exhibit set forth in Item 9.01 hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1* Teladoc Health, Inc. press release, dated February 2 0 , 202 4 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Furnished herewith. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 20, 2024 Teladoc Health, Inc. By: /s/ Adam C. Vandervoort Name: Adam C. Vandervoort Title: Chief Legal Officer and Secretary